Results 101 to 110 of about 1,761 (189)

IFN-α armed gE elicits superior immunogenicity compared to unmodified antigens and flagellin armed gE in mice

Vaccine: X
Herpes zoster (HZ) induces significant pain and discomfort, which can seriously affect the quality of life of patients. At present, there is no specific treatment for HZ, and the mosteffective HZ control is vaccination. The main obstacle to developing an
Jiangang Zhang, Shaodan Peng, Fang Xu, Ying Qiao, Xiaoke Ye, Yu Guan, Xiaolong Zhao, Yueran Wang, Zhongqi Shao, Tao Zhu, Weixue Si   +10 more
doaj   +1 more source

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018–2024

Human Vaccines & Immunotherapeutics
This post-marketing safety study evaluated the co-administration of recombinant zoster vaccine (RZV, Shingrix) and influenza vaccines (HD-IIV/aIIV/RIV) in adults aged ≥ 65 years using U.S. VAERS data (2018–2024).
Yihao Li, Huilin Xia, Hong Zhang, Yuan Lu, Hang Zhou, Rongbin Yu, Peng Huang   +6 more
doaj   +1 more source

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) \u2014 United States, October 2017\u2013June 2018: Supplementary Table 1. Search Strategy to Identify Recombinant Zoster Vaccine (RZV) Reports of Selected Pre-specified Outcomes in the Vaccine Adverse Events Reporting System (VAERS) \u2014 United States, October 2017\u2013June 2018 [PDF]

Supplementary Table for: Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) \u2014 United States, October 2017\u2013June ...

core  

Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster

Vaccines
Background/Objectives: Approved mRNA vaccines commonly use sequences modified with pseudouridine to enhance translation efficiency and mRNA stability.
Shun Zhang, Xiaojie Wang, Tongyi Zhao, Chen Yang, Lulu Huang   +4 more
doaj   +1 more source

Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort

Vaccines
Background: Patients with rheumatic diseases (RMDs) are at increased risk of herpes zoster (HZ), particularly when receiving immunosuppressive treatment.
Silvia Valentini, Jurgen Sota, Irene Fineschi, Edoardo Conticini, Estrella Garcia-Gonzalez, Emilio D’Ignazio, Marco Bardelli, Stefano Gentileschi, Marta Fabbroni, Francesca Bellisai, Paolo Falsetti, Enrico Selvi, Luca Cantarini, Bruno Frediani, Caterina Baldi   +14 more
doaj   +1 more source

Therapeutics Letter 114

, 2018
Therapeutics Letter 114 looks at Shingrix, a new vaccine for shingles. Conclusions: Compared to placebo the Shingrix vaccine reduced the incidence of herpes zoster by 3.26 % (NNV = 31) over 3.5 years in all age groups and reduced the incidence of post ...
Therapeutics Initiative (University of British Columbia)
core  

Unlocking the value of Shingrix: how vaccination empowers older adults

Microbiology Australia
Shingles, and its often-debilitating complication post-herpetic neuralgia (PHN), is a common condition, particularly in older populations whose immune systems have declined with age. As the number of older people continues to rise globally, healthy aging becomes an ever-increasing priority from a public health perspective.
Katie L. Flanagan, James G. Wood
openaire   +1 more source

바이러스 재활성 혹은 백신에 의해 유도된 수두-대상포진 바이러스 특이적인 T 세포의 특성 규명

, 2022
학위논문(박사) - 한국과학기술원 : 의과학대학원, 2022.8,[v, 59 p. :]the responses by vaccination in mice and the responses by VZV reactivation in HZ patients. I evaluated the immunogenicity of a newly formulated gE protein-based HZ vaccine containing Second-generation Lipid
Nam, Hyo Jung
core  

Morbidity and Mortality Weekly Report (MMWR) [PDF]

Supplements: Post-licensure safety Surveillance of recombinant zoster vaccine (Shingrix) \u2014Vaccine Adverse Event Reporting System (VAERS), United States, October 2017\u2013June ...

core   +1 more source

Protect your patients with the new shingles vaccine [PDF]

CDC recommends new shingles vaccine (Shingrix) for adults 50 and older .shingles-factsheet-hcp ...

core